Charles M. Rudin
Memorial Sloan Kettering Cancer Center · 1,735 works · 88,053 citations · h-index 136
Top works
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- Akt Stimulates Aerobic Glycolysis in Cancer Cells
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin
- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
- Expression of bcl-xL can confer a multidrug resistance phenotype
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- Small-cell lung cancer
- Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors